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Abstract There is a general consensus in dentistry that successful
local anesthesia is frequently difficult in habitual drinkers and alcoholic
patients. Neuro-active tetrahydroharmans increase in human body
fluids and tissues by consuming alcoholic beverages. To understand
such reduced anesthetic efficacy by the drug interaction hypothesis,
we studied the influences of drinking-related tetrahydroharmans on
membrane fluidization as one of local anesthetic mechanisms. Lipo-
somal membranes prepared with phosphatidylcholine and cholesterol
were treated with lidocaine and different tetrahydroharmans separately
and in combination, followed by measuring fluorescence polarization
to determine their induced changes in membrane fluidity. In contrast
to 0.1–2 mg/mL lidocaine, tetrahydroharmans decreased the fluidity
of membrane preparations at ∼ 25μg/mL with the potency being
1,2,3,4-tetrahydroharman  1,2,3,4-tetrahydronorharman. 1,2,3,4-
Tetrahydroharman counteracted the membrane-fluidizing effects
of 1 mg/mL lidocaine at physiologically relevant 0.25–2.5 ng/mL,
whereas neither its 6-hydroxyl nor 7-hydroxyl metabolite did at
25–200 ng/mL. Such counteraction at a membrane lipid level may be
responsible for the reduction of local anesthetic efficacy in drinkers
because 1,2,3,4-tetrahydroharman increases in vivo by ingesting
alcoholic beverages.
Keywords drinking; local anesthesia; reduced efficacy; lidocaine;
tetrahydroharman; membrane effect
1. Introduction
Habitual alcohol consumption or chronic alcoholism
induces not only pathophysiological changes such as
liver disease, cardiomyopathy, coagulation alteration,
gastrointestinal disturbance, and CNS dysfunction but
also pharmacokinetic and pharmacodynamic changes
of various drugs, especially neuro-active agents such
as anesthetics and sedatives [2,10,22,29]. In heavy
drinkers or alcoholic patients, clinicians experience the
decreased responses to or the increased dose requirements
of general anesthetics in the intra-operative period [2].
Chronic alcoholism and experimental alcohol treatment
make patients and animals less susceptible to general
anesthetics, resulting in an increase of the effective dose
for anesthesia (induction, sensory block, consciousness loss
and maintenance) as reported for intravenous anesthetic
barbiturates, benzodiazepines, and propofol [5,8,17,24]
and inhalational anesthetic isoflurane and nitrous oxide [10,
14]. Such reduction of general anesthetic efficacy has been
attributed to metabolic alteration, enzymatic induction,
clearance enhancement, increased liver solubility, and
cross-tolerance [4,8,22,29].
Local anesthesia is also affected by habitual drinking
and chronic alcoholism as well as general anesthesia.
Especially in dentistry, there is a general consensus that
patients with heavy or long-term drinking habits face
difficulty in obtaining satisfactory analgesia with local
anesthetics or achieving adequate local anesthesia as
described in anecdotal and case reports [16]. In animal
experiments, chronic alcohol intake produces the tolerance
of rats to local anesthetic lidocaine [3]. Unlike general
anesthetics, however, the molecular mode of action is
still arguable for the altered local anesthetic effects
because pharmacokinetic mechanisms and liver uptake
changes are not directly applicable to local anesthetics.
It has been theorized based on the physiological changes
induced by alcohol itself, including the metabolic acidosis
which decreases the ability of drug molecules to diffuse
through nerve sheaths and penetrate into neuronal cell
membranes, and the regional vasodilation which increases
blood flow and carries away drug molecules from the
injection site. However, the acidosis was recently revealed
not to essentially contribute to the local anesthetic failure
associated with pathophysiological acidic conditions [37].
The vascular effects of alcoholic beverages are not
necessarily vasodilative, but rather vasoconstrictive to
produce hypertension [7]. With respect to the reduced
efficacy of lidocaine, Fassoulaki et al. [3] suggested a
pharmacodynamic mechanism, that is, a physicochemical
change of neuronal membranes.
Besides voltage-gated sodium channels of neural and
cardiac cells, local anesthetics act on membrane lipids
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Figure 1: Structures of tetrahydroharmans.
to modify the physicochemical properties like fluidity
of artificial and biological membranes, thereby directly
affecting the function of biomembranes and indirectly
modulating the activity of ion channels through the
conformational changes of transmembrane proteins [40].
Drug-induced membrane fluidization is referred to as one of
pharmacological mechanisms for local anesthetics [34].
1,2,3,4-Tetrahydroharman (THH), 1,2,3,4-tetrahy-
dronorharman (THNH), and their structural relatives are
present in the human body and also contained in various
alcoholic beverages. THH and THNH are produced by the
condensation reaction between tryptamine and aldehyde
or α-keto acid (Figure 1). THH is metabolized to 6-
hydroxy-1,2,3,4-tetrahydroharman (6-OH-THH) and 7-
hydroxy-1,2,3,4-tetrahydroharman (7-OH-THH). These
tetrahydroharmans significantly increase in body fluids and
tissues in association with alcohol beverage consumption
due to their increased exogenous supply and their promoted
endogenous production [11,36]. Certain tetrahydroharmans
were recently found to affect a membrane-acting drug at a
membrane lipid level [32]. In this study, we examined
whether THH, THNH, 6-OH-THH, and 7-OH-THH
influenced the membrane-fluidizing effects of lidocaine
to get a clue to mechanistically understand the reduction
of local anesthetic efficacy associated with habitual
drinking.
2. Materials and methods
2.1. Chemicals
Lidocaine was purchased from Sigma-Aldrich (St. Louis,
MO, USA). THH, 6-OH-THH, 7-OH-THH, and THNH
were synthesized as reported previously [35]. 1,2-Dipalmi-
toylphosphatidylcholine (DPPC) and 1-palmitoyl-2-
oleoylphosphatidylcholine (POPC) were obtained from
Avanti Polar Lipids (Alabaster, AL, USA), cholesterol from
Wako Pure Chemicals (Osaka, Japan), and N -phenyl-1-
naphthylamine (PNA) from Funakoshi (Tokyo, Japan).
Dimethyl sulfoxide (DMSO) of spectroscopic grade
(Kishida, Osaka, Japan) was used for preparing reagent
solutions. All other chemicals were of the highest grade
commercially available.
2.2. Membrane preparation
Liposomal membranes with the lipid bilayer structure were
prepared to be unilamellar vesicles (total lipids of 0.14 mM)
suspended in 10 mM Tris-HCl buffer of pH 7.4 containing
125 mM NaCl, 5 mM KCl, and 0.1 mM EDTA according
to the method of Peura et al. [26]. Their lipid compositions
were (1) 100 mol% DPPC (DPPC membranes) which
have been most frequently used as model membranes for
studying membrane-acting drugs and (2) 60 mol% POPC
and 40 mol% cholesterol (POPC/cholesterol membranes) to
mimic neuronal cell membranes [32].
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Figure 2: Effects of lidocaine on DPPC membranes and
POPC/cholesterol membranes. Lidocaine was subjected to
the reaction with membrane preparations at the indicated
concentrations. Fluorescence polarization changes from
controls were determined after labeling the membranes with
PNA. Values are expressed as means ±SEM (n= 7). ∗∗P <
.01 compared with controls.
2.3. Membrane effects of lidocaine and tetrahydroharmans
The solutions of lidocaine and tetrahydroharmans in DMSO
were applied to the membrane preparations so that a final
concentration was 0.1–2 mg/mL for lidocaine, 2 ng/mL to
25μg/mL for THH, 20 ng/mL to 25μg/mL for THNH,
2–200 ng/mL for 6-OH-THH, and 2–200 ng/mL for 7-OH-
THH. The concentration of DMSO vehicle was adjusted
to be 0.5% (v/v) of the total volume so as not to affect the
fluidity of intact membranes. DMSO of the corresponding
volume was added to controls. After the reaction at 37 °C
for 30 min, the membranes were labeled with PNA [34], a
fluorescent probe which penetrates into lipid bilayers and
localizes in their hydrophobic upper regions. Since PNA is
subject to the rotational restriction imparted by membrane
fluidity or rigidity, drugs acting on lipid bilayers to produce
more fluid membranes facilitate the probe rotation to emit
the absorbed light in all directions, decreasing fluorescence
polarization. Fluorescence polarization of the membrane
suspensions was measured by an RF-540 spectrofluorometer
(Shimadzu, Kyoto, Japan) equipped with a polarizer at
350 nm for excitation and 425 nm for emission as reported
previously [33]. Polarization values were calculated by the
formula (IV V −GIV H )/(IV V +GIV H ), in which I is the
fluorescence intensity and the subscripts V and H refer
to the vertical and horizontal orientations of the excitation
and emission polarizers, respectively [38]. The grating
correction factor (G = IHV /IHH ) was used to correct the
polarizing effects of a monochromator. Compared with
controls, a decrease and an increase of polarization values
mean an increase (membrane fluidization) and a decrease of
membrane fluidity (membrane rigidification), respectively.
2.4. Influences of tetrahydroharmans on lidocaine mem-
brane effects
DPPC membranes or POPC/cholesterol membranes were
pretreated at 37 °C for 30 min with THH, THNH, 6-
OH-THH, and 7-OH-THH of a final concentration being
0.25 ng/mL to 5μg/mL, 5–25μg/mL, 25–200 ng/mL, and
25–200 ng/mL, respectively. The pretreated and not-treated
membranes were subjected to the reaction with lidocaine
(a final concentration of 1 mg/mL) at 37 °C for 30 min,
followed by measuring PNA fluorescence polarization as
described above. Tetrahydroharmans and lidocaine were
applied as DMSO solutions to the membrane preparations
and the concentration of DMSO vehicle was 0.5% (v/v)
of the total volume. Control experiments were conducted
with the addition of an equivalent volume of DMSO. The
inhibition (%) of lidocaine membrane effects was obtained
by comparing polarization decreases induced by lidocaine
with those by tetrahydroharman pretreatments.
2.5. Data analysis
Results are expressed as means ±SEM (n = 7). Data were
statistically analyzed by a one-way analysis of variance
(ANOVA) followed by a post hoc Fisher’s protected least
significant difference (PLSD) test using StatView 5.0 (SAS
Institute, Cary, NC, USA). P values < .05 were considered
significant.
3. Results
Lidocaine acted on both DPPC membranes and POPC/
cholesterol membranes to increase their fluidity at 0.1–
2 mg/mL as shown by PNA polarization decreases (Fig-
ure 2). The membrane-fluidizing potency varied according
to lidocaine concentrations and membrane lipid composi-
tions.
In contrast to lidocaine, THH and THNH decreased the
membrane fluidity at ng/mL to low μg/mL concentrations,
while THH was more effective in membrane rigidification
than THNH. These tetrahydroharmans decreasingly influ-
enced the DPPC membrane-fluidizing effects of 1 mg/mL
lidocaine at ∼ 25μg/mL with the potency being THH 
THNH.
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Figure 3: Effects of THH and its hydroxyl metabo-
lites on POPC/cholesterol membranes. THH, 6-OH-THH,
and 7-OH-THH were subjected to the reaction with
POPC/cholesterol membranes at the indicated concentra-
tions. Fluorescence polarization changes from controls were
determined after labeling the membranes with PNA. Values
are expressed as means ±SEM (n= 7). ∗P < .05 and ∗∗P <
.01 compared with controls.
THH and its two hydroxyl metabolites differently acted
on POPC/cholesterol membranes in a ng/mL concentration
range (Figure 3). THH decreased the membrane fluidity,
whereas neither 6-OH-THH nor 7-OH-THH affected it.
THH counteracted the fluidizing effects of 1 mg/mL
lidocaine on POPC/cholesterol membranes at 0.25–
2.5 ng/mL (Figure 4). However, 6-OH-THH and 7-OH-THH
showed no significant counteraction even at 25–200 ng/mL.
4. Discussion
Our main findings are as follows: (1) lidocaine acts on lipid
bilayers to increase the fluidity of DPPC membranes and
POPC/cholesterol membranes at sub-mg/mL to low mg/mL
concentrations; (2) tetrahydroharmans decrease the mem-
brane fluidity to show the relative potency being THH 
THNH; and (3) the membrane-fluidizing effects of lidocaine
are counteracted by 0.25–2.5 ng/mL THH, but neither by 6-
OH-THH nor by 7-OH-THH.
Figure 4: Counteraction of lidocaine membrane effects
by THH. POPC/cholesterol membranes were pretreated
with THH, 6-OH-THH, or 7-OH-THH of the indicated
concentrations, followed by the reaction with 1 mg/mL
lidocaine. The inhibition (%) of membrane-fluidizing effects
of lidocaine was obtained by comparing PNA fluorescence
polarization decreases induced by lidocaine with those by
THH, 6-OH-THH, or 7-OH-THH pretreatments. Values are
expressed as means ±SEM (n= 7). ∗P < .05 and ∗∗P < .01
compared with controls.
Biomembranes play an important role as the dynamic
environments to modulate the structures and functions
of transmembrane or membrane-embedded proteins. Ion
channels regulate the flux of ions across membrane lipid
bilayers through the changes of protein conformation which
is influenced not only by a binding of ligands to channels
but also by an alteration of the lipid microenvironments
surrounding channels. Among membrane physicochemical
properties, fluidity appears to govern the dynamics
of ion channels [31], and to determine the activity
of sodium channels [9]. In this study, lidocaine has
been revealed to increase the fluidity of both DPPC
membranes and POPC/cholesterol membranes. Lidocaine
induces larger fluidity changes in DPPC membranes
than in POPC/cholesterol membranes, suggesting that
membrane fluidization depends on the lipid composition. Its
membrane effects are consistent with the previous reports
of local anesthetics to fluidize artificial and synaptosomal
membranes [33,40]. The membrane-acting concentrations
(0.1–2 mg/mL) of lidocaine are lower than or almost
correspond to its clinically used concentrations. A relatively
large volume of high concentration local anesthetics is
commonly injected to ensure adequate anesthesia for
surgery; that is, 20–30 mL of 20 mg/mL lidocaine are
typically injected to block large nerves in humans [28]. All
nociceptive C-fibers of rat sciatic nerves are blocked by the
continuous superfusion with 0.33 mg/mL lidocaine [13].
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Intra-neural lidocaine is related to its nerve-blocking degree
and to its applied concentration. Lidocaine is likely to be
concentrated in membrane lipid bilayers so that its intra-
membrane concentrations are higher than its concentrations
in the bulk aqueous phase [28,30]. The effect to modify
membrane fluidity is considered to underlie the local
anesthetic action of lidocaine.
We characterized the membrane activities of tetrahydro-
harmans of physiologically relevant concentrations which
are presumed to be sub-ng/mL to low ng/mL levels in
human blood [15,18] and then investigated their influences
on local anesthetic membrane effects when lidocaine and
tetrahydroharmans were used concurrently. Consequently,
in contrast to membrane-fluidizing lidocaine, THH has
been revealed to decrease the membrane fluidity more
potently than THNH, suggesting the importance of a methyl
group at the 1-position. By pretreating POPC/cholesterol
membranes, THH has been proved to decrease the
membrane effects of lidocaine at 0.25–2.5 ng/mL, but
not its hydroxyl metabolites.
THH, THNH, and harman compounds significantly
increase in the human body in association with drinking
behaviors and alcohol intake [11,36]. One of the general
personality characteristics of habitual drinkers and chronic
alcoholics is smoking. In addition to alcoholic beverages,
cigarette smoke may be the source of THH and its structural
relatives because they are contained in the mainstream
and sidestream [27]. Their plasma concentrations are
remarkably increased by alcoholic beverage ingestion and
also possibly by tobacco smoking [1].
Clinicians often experience that local anesthetics
are less effective on patients with a history of alcohol
abuse and heavy drinking habits [6,16]. Chronic alcohol
consumption produces the tolerance to lidocaine and
increases its dose requirement for local anesthesia, which
is not attributed to a change in lidocaine pharmacokinetics,
but to a pharmacodynamic change of biomembranes [3].
Adaptation to the membrane fluidization induced by
alcohol would result in a fluidity change of neuronal
cell membranes or an alteration in neuronal susceptibility
to alcohol membrane effects. Such resulting membrane
rigidification potentially resists the membrane-fluidizing
effects of local anesthetics. In alcoholic patients, erythrocyte
membranes show a decrease in membrane fluidity or
a pharmacodynamic tolerance to alcohol together with
altering the membrane lipid composition [20,25]. Besides
the membrane adaptation to alcohol, THH is able to
physicochemically modify neuronal membranes.
Since tetrahydroharmans and their related compounds
significantly increase in vivo by ingesting alcoholic
beverages [23,36], our results suggest the possibility
that THH counteracts the membrane effects of lidocaine
and this counteraction may be at least partly responsible
for local anesthetic failures in habitual drinkers and
alcoholic patients. The counteracting activity is confined
to THH, not found in 6-OH-THH and 7-OH-THH.
Tetrahydroharmans are subjected to the metabolism
catalyzed by cytochrome P450 enzymes in the human body,
where THH is hydroxylated to form 6-OH-THH and 7-OH-
THH [35]. Both hydroxyl metabolites are far less active on
membrane lipid bilayers than THH because of their higher
hydrophilicity. CYP2D6 and CYP2E1, which belong to
the super family of cytochrome P450, are involved in the
metabolism of tetrahydroharmans [12,39]. CYP2D6 and
CYP2E1 are inducible by alcohol exposure and in chronic
alcoholics [19,21]. If such enzymatic induction occurs, the
metabolism of THH would be enhanced, with a resultant
decrease of its membrane activity, thereby leading to the
failure to counteract the membrane effects of lidocaine.
While local anesthetics are known to be less effective on
habitual drinkers and chronic alcoholics, the reduction of
anesthetic efficacy may differ depending on patients. The
induction of CYP isozymes converting membrane-active
THH to membrane-inactive metabolites could underlie this
difference.
5. Conclusion
Lidocaine increases the fluidity of lipid bilayer membranes
at clinically relevant concentrations as one of local
anesthetic mechanisms, whereas drinking-related THH
decreases that at physiologically presumable concentrations.
The membrane-fluidizing effects of lidocaine are counter-
acted by membrane-rigidifying THH. Such counteraction at
a membrane lipid level may be related to the alteration of
local anesthetic efficacy occasionally observed in habitual
drinkers and alcoholic patients because THH increases in
vivo by ingesting alcoholic beverages.
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